Cited by 613Coffee research and impactsAgricultural safety and regulationsDye analysis and toxicity

Scientific Opinion on the safety of caffeine

Open access
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)·2015·EFSA Journal

Abstract

Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies was asked to deliver a scientific opinion on the safety of caffeine, providing advice on caffeine intakes, from all dietary sources that do not give rise to concerns about adverse health effects for the general healthy population and subgroups thereof. Possible interactions between caffeine and other constituents of so-called “energy drinks”, alcohol, p-synephrine and physical exercise should also be addressed. Single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) do not give rise to safety concerns. The same amount does not give rise to safety concerns when consumed < 2 hours prior to intense physical exercise under normal environmental conditions. Other constituents of “energy drinks” at typical concentrations in such beverages (about 300–320, 4 000 and 2 400 mg/L of caffeine, taurine and d-glucurono-γ-lactone, respectively), as well as alcohol at doses up to about 0.65 g/kg bw, would not affect the safety of single doses of caffeine up to 200 mg. Habitual caffeine consumption up to 400 mg per day does not give rise to safety concerns for non-pregnant adults. Habitual caffeine consumption up to 200 mg per day by pregnant women does not give rise to safety concerns for the fetus. Single doses of caffeine and habitual caffeine intakes up to 200 mg consumed by lactating women do not give rise to safety concerns for breastfed infants. For children and adolescents, the information available is insufficient to derive a safe caffeine intake. The Panel considers that caffeine intakes of no concern derived for acute caffeine consumption by adults (3 mg/kg bw per day) may serve as a basis to derive single doses of caffeine and daily caffeine intakes of no concern for these population subgroups.

Verified 2026-10-10 · 1 reference not checked yet

AI snapshot

Written from a shortened version of the paper’s full text (it is longer than we read).

TL;DR

The EFSA NDA Panel concluded that single caffeine doses up to 200 mg (about 3 mg/kg bw for a 70-kg adult) and habitual intake up to 400 mg/day do not raise safety concerns for healthy non-pregnant adults, with lower levels for pregnant and lactating women. For children and adolescents, data were insufficient to derive a safe intake, but the Panel proposed 3 mg/kg bw/day for single and habitual consumption.

Key findings

  • For healthy adults, single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) from all sources do not give rise to safety concerns, including when consumed less than two hours before intense physical exercise under normal environmental conditions; 100 mg may increase sleep latency and reduce sleep duration in some adults, especially close to bedtime. Habitual caffeine intake up to 400 mg/day (about 5.7 mg/kg bw/day for a 70-kg adult) does not give rise to safety concerns for healthy adults, except pregnant women.
  • For pregnant women, habitual caffeine intake up to 200 mg/day does not give rise to safety concerns for the fetus; for lactating women, single doses up to 200 mg and habitual intake of 200 mg/day do not give rise to safety concerns for the breastfed infant, with infant intakes estimated not to exceed 0.3 mg/kg bw/day, 10-fold below the lowest tested dose of 3 mg/kg bw.
  • For children and adolescents, available information was insufficient to derive a safe caffeine intake; the Panel considered that the adult single-dose level of 3 mg/kg bw/day may also apply to children, and proposed 3 mg/kg bw/day for habitual consumption. The 95th percentile of single-day caffeine intake exceeded 3 mg/kg bw in 6/16 countries for adolescents, 9/16 for children, and 3/10 for toddlers, with proportions of survey days ranging from about 7–12%, 6–15%, and 7–37%, respectively.
  • Other common “energy drink” constituents at typical concentrations (about 300–320, 4,000, and 2,400 mg/L of caffeine, taurine, and D-glucurono-γ-lactone, respectively) and alcohol up to about 0.65 g/kg bw (blood alcohol concentration about 0.08%) would not affect the safety of single caffeine doses up to 200 mg; whether p-synephrine modifies acute cardiovascular effects of caffeine was not adequately investigated, so no conclusions could be drawn.

Methods

  • The EFSA NDA Panel conducted a scientific opinion based on previous risk assessments and human intervention and observational studies, preferring human intervention and prospective cohort studies over case-control and cross-sectional studies; case reports of adverse events were not used to derive levels of no concern.
  • Dietary caffeine intake was estimated using the EFSA Comprehensive European Food Consumption Database, containing 39 surveys in 22 European countries for 66,531 participants, plus the EFSA report on “energy drinks” involving more than 52,000 participants from 16 Member States for single-session intakes.
  • The assessment covered cardiovascular outcomes, hydration and body temperature, central nervous system outcomes (sleep, anxiety, perceived exertion, subjective alcohol intoxication), and pregnancy outcomes, using systematic reviews and meta-analyses where available.

Limitations

  • The paper states that data are particularly scarce for pregnant and lactating women, absent for caffeine-containing supplements, and that surveys differ in methodology so direct country-to-country comparisons should be cautious; no studies were available in pregnant women or middle-aged/elderly subjects undertaking intense physical exercise.
  • The paper states that p-synephrine interactions with caffeine have not been adequately investigated, that information for children and adolescents is insufficient to derive a safe intake, and that prospective cohort studies cannot prove causality for pregnancy outcomes, although the Panel assumed causality for the safety assessment.
  • Evident from the text: the “single session” time frame in the energy drink report is imprecise, energy drink consumers may not represent the general population, food-frequency questionnaires may overestimate consumption of specific foods, and observational studies are subject to confounding, reverse causality, and recall bias.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2903/j.efsa.2015.4102

Cites

295 of 296 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 175 cited sources checked · 0 supported · 0 flagged

  • Findingnone given

    There are no studies on the health effects of single doses of caffeine consumed by pregnant women prior to intense physical exercise.

    “There are no studies on the health effects of single doses of caffeine consumed by pregnant women prior to intense physical exercise.”
    • Also stated in: § 5.2. Pregnant women 5.2.1. Single doses of caffeine · plain
      “There are no studies on the health effects of single doses of caffeine consumed by pregnant women prior to intense physical exercise.”
    Quote in the paperNot a substantial claim
  • Findingnone given

    Data to characterise the risk of habitual caffeine consumption in pregnant women are scarce.

    “Data to characterise the risk of habitual caffeine consumption in this population subgroup are scarce.”
    Quote in the paperNot a substantial claim
  • Findingreasoning

    At doses of up to 200 mg consumed by lactating women, daily caffeine intakes by the breastfed infant would not exceed 0.3 mg/kg bw, which is 10-fold below the lowest dose of 3 mg/kg bw tested in a dose finding study and at which no adverse effects were observed in the majority of infants.

    “At these doses of caffeine, daily caffeine intakes by the breastfed infant would not exceed 0.3 mg/kg bw, which is 10-fold below the lowest dose of 3 mg/kg bw tested in a dose finding study and at which no adverse effects were observed in the majority of infants.”
    Quote in the paperSubstantial claim
  • Findingnone given

    In 7 out of 13 countries, the 95th percentile of daily caffeine intake from foods and beverages exceeded 400 mg.

    “In 7 out of 13 countries, the 95 th percentile of daily caffeine intake from foods and beverages exceeded 400 mg.”
    Quote in the paperNot a substantial claim
  • Findingnone given

    Single doses of 100 mg (about 1.4 mg/kg bw for a 70-kg adult) of caffeine may increase sleep latency and reduce sleep duration in some adult individuals, particularly when consumed close to bedtime.

    “Single doses of 100 mg (about 1.4 mg/kg bw for a 70-kg adult) of caffeine may increase sleep latency and reduce sleep duration in some adult individuals, particularly when consumed close to bedtime.”
    Quote in the paperSubstantial claim
  • May combine two claims. 162
  • The quote only partly states this claim. 15
  • Classified as probably not a substantial claim. 46
  • May combine two claims. The quote only partly states this claim.

    Findingnone given

    About 6% of the adult population may exceed 200 mg of caffeine in a single session of energy drink consumption, and about 4% do so in connection with physical exercise.

    “About 6 % of the adult population may exceed 200 mg of caffeine in a single session of”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The proportion of survey days in which the level of 3 mg/kg bw was exceeded ranged from about 7 to 12% in adolescents, from 6 to 15% in children and from 7 to 37% in toddlers in the aforementioned countries.

    “The proportion of survey days in which the level was exceeded ranged from about 7 to 12 % in adolescents, from 6 to 15 % in children and from 7 to 37 % in toddlers in the aforementioned countries.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.

    Findingnone given

    There are no data to characterise the risk of single doses of caffeine consumed by lactating women, and data on habitual caffeine consumption in this population subgroup are scarce.

    “There are no data to characterise the risk of single doses of caffeine consumed by lactating women, and data on habitual caffeine consumption in this population subgroup are scarce.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingreasoning

    As only limited studies are available on the longer-term effects of caffeine on anxiety and behaviour in children and adolescents, there is substantial uncertainty regarding longer-term effects of habitual caffeine consumption in this age group.

    “As only limited studies are available on the longer-term effects of caffeine on anxiety and behaviour in children and adolescents, there is substantial uncertainty regarding longerterm effects of habitual caffeine consumption in this age group.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The proportion of subjects exceeding that level of intake in the above-mentioned countries was about 5 to 10% for adolescents, 6 to 13% for children and about 6% for toddlers.

    “The proportion of subjects exceeding that level of intake in the above-mentioned countries was about 5 to 10 % for adolescents, 6 to 13 % for children and about 6 % for toddlers.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingnone given

    The question of whether p-synephrine modifies the acute cardiovascular effects of single doses of caffeine has not been adequately investigated in humans, particularly if consumed shortly before intense physical exercise, and therefore no conclusions could be drawn.

    “The question of whether or not p-synephrine modifies the acute cardiovascular effects of single doses of caffeine has not been adequately investigated in humans, particularly if consumed shortly before intense physical exercise, and therefore no conclusions could be drawn.”
    • Also stated in: § 5.1.2. Single doses of caffeine in combination with other common constituents of "energy drinks", alcohol and p-synephrine · plain
      “The Panel also considers that the question of whether or not p-synephrine modifies the acute cardiovascular effects of single doses of caffeine has not been adequately investigated in humans, particularly if consumed shortly before intense physical exercise, and therefore no conclusions could be drawn.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingnone given

    Chocolate beverages were important contributors to total caffeine intakes in children and toddlers in most countries, and the use of a conservative caffeine value for this food category may have led to an overestimation of caffeine intakes in these age groups.

    “Chocolate beverages were important contributors to total caffeine intakes in children and toddlers in most countries, and the use of a conservative caffeine value for this food category may have led to an overestimation of caffeine intakes in these age groups.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation

    The conclusion that caffeine intakes up to 200 mg per day by pregnant women do not give rise to safety concerns for the fetus is based on prospective cohort studies showing a dose-dependent positive association between caffeine intakes during pregnancy and the risk of adverse birth weight-related outcomes (fetal growth retardation, small for gestational age) in the offspring.

    “This conclusion is based on prospective cohort studies showing a dose-dependent positive association between caffeine intakes during pregnancy and the risk of adverse birth weight-related outcomes (i.e.fetal growth retardation, small for gestational age) in the offspring.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The estimated 95th percentile of caffeine intake from foods and beverages on a single day exceeded 3 mg/kg bw in 6 out of 16 countries for adolescents (10 to <18 years), in 9 out of 16 countries for children (3 to <10 years) and in 3 out of 10 countries for toddlers (12 to <36 months).

    “The estimated 95 th percentile of caffeine intake from foods and beverages on a single day exceeded 3 mg/kg bw in 6 out of 16 countries for adolescents (10 to < 18 years), in 9 out of 16 countries for children (3 to < 10 years) and in 3 out of 10 countries for toddlers (12 to < 36 months).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given

    This information (proportion exceeding 200 mg in a single session) is not available for other sources of caffeine.

    “This information is not available for other sources of caffeine.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingreasoning

    In these countries, the estimated proportion of the adult population exceeding daily intakes of 400 mg ranged from about 6% to almost one-third (33%), and coffee was the main source of caffeine.

    “In these countries, the estimated proportion of the adult population exceeding daily intakes of 400 mg ranged from about 6 % to almost one-third (33 %), and coffee was the main source of caffeine.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingnone given

    The question of whether p-synephrine modifies the acute cardiovascular effects of single doses of caffeine or the long-term effects of caffeine on the cardiovascular system has not been adequately investigated in humans and therefore no conclusions could be drawn.

    “The question of whether or not p-synephrine modifies the acute cardiovascular effects of single doses of caffeine or the long-term effects of caffeine on the cardiovascular system has not been adequately investigated in humans and therefore no conclusions could be drawn.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Sufficient days (n ≥ 60) to obtain statistically robust 95th percentiles for toddlers regarding caffeine intakes from different sources on consumption days were available only for chocolate and tea, for which the highest values across Member States were 5.3 and 9.6 mg/kg bw per day, respectively.

    “Sufficient (n ≥ 60) days to obtain statistically robust 95 th percentiles for toddlers regarding caffeine intakes from different sources on consumption days were available only for chocolate and tea, for which the highest values across Member States were estimated to be 5.3 and 9.6 mg/kg bw per day of caffeine, respectively (Appendix C).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based). May combine two claims. The quote only partly states this claim.

    Findingcitation

    In adolescent energy drink consumers, mean caffeine intake from energy drinks in a single session was 176 mg and 95th percentile was 450 mg.

    “The mean and 95 th percentile of caffeine intakes in a”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zucconi et al., 2013

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    For lactating women in Greece, mean daily caffeine intake from all sources was 31 mg and 95th percentile was 97 mg per day.

    “The mean and the 95 th percentile of the daily caffeine intake from all sources were 31 mg and 97 mg per day, respectively (Appendix B).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The highest contribution to total caffeine intakes from energy drinks for adolescents was in the UK (11%), followed by the Netherlands (8.1%) and Belgium (5.3%).

    “The highest contribution to total caffeine intakes from”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    For adolescents, the highest 95th percentiles of caffeine intake on a single day were 240 mg and 4.3 mg/kg bw.

    “The highest 95 th percentiles of caffeine intake on a single day in absolute values and on a per kg bw basis were 240 mg and 4.3 mg/kg bw, respectively (Appendices C and D).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Among countries, mean daily caffeine intake for adolescents ranged from 18 to 70 mg and 95th percentile from 61 to 212 mg.

    “Means and 95 th percentiles ranged from 18 to 70 mg and from 61 to 212 mg, respectively, among countries (Table 2, Appendix B).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    On a per kg bw basis, the highest 95th percentile of caffeine intake on a single day for adolescents was from coffee (7.1 mg), followed by chocolate (5.4 mg), energy drinks (5.2 mg), tea (5.0 mg) and cola beverages (2.4 mg).

    “On a per kg bw basis, the highest 95 th percentile of caffeine intake was from coffee (7.1 mg), followed by chocolate (5.4 mg),”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation

    In adolescent energy drink consumers, 51, 25, 11, 6 and 7% declared consuming one, two, three, four and five or more cans of energy drinks within a single session.

    “In this survey, 51, 25, 11, 6 and 7 % of”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zucconi et al., 2013

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    In most countries, chocolate (including cocoa drinks) was the predominant source of caffeine for children aged 3 to 10 years, followed by tea and cola drinks.

    “In most countries,”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation

    In adult energy drink consumers, mean caffeine intake from energy drinks in a single session was 155 mg and 95th percentile was 344 mg.

    “The mean and 95 th percentile of caffeine intakes in a”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zucconi et al., 2013

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    The highest 95th percentiles of caffeine intake on a single day for adults from energy drinks, tea and cola were 330, 308 and 216 mg, respectively.

    “The highest 95 th percentiles of caffeine intake from”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Among countries, mean daily caffeine intake from all sources for adults ranged from 37 to 319 mg and 95th percentile from 109 to 742 mg.

    “Means and 95 th percentiles ranged from 37 to 319 mg and from 109 to 742 mg, respectively, among countries (Table 2, Appendix B).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation

    In adult energy drink consumers, 52, 29, 11, 5 and 3% declared consuming one, two, three, four and five or more cans of energy drinks within a single session.

    “In this survey, 52, 29, 11, 5 and 3 % of”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zucconi et al., 2013

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    Tea or chocolate was the main caffeine source in all toddler surveys except Belgium, where cola drinks contributed the most (58%).

    “Tea or chocolate was the main caffeine source in all surveys except for Belgium, where cola drinks contributed the most to total caffeine intake (58 %; Appendix E).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given

    For toddlers, 10 surveys were available.

    “For toddlers, 10 surveys were available.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based). May combine two claims. The quote only partly states this claim.

    Findingnone given

    The highest 95th percentiles of caffeine intake on a single day for adolescents from energy drinks, tea, chocolate and cola were 330, 308, 253 and 142 mg, respectively.

    “The highest 95 th percentiles of caffeine intake from”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In adolescents, chocolate was the main contributor to caffeine intake in six surveys, coffee in four, cola beverages in three, and tea in two.

    “Chocolate was the main contributor to caffeine intake in six surveys, coffee was the main contributor in four surveys, cola beverages were the main contributors in three surveys and tea was the main contributor in two surveys.”
    Quote in the paperNot a substantial claim
  • May combine two claims. The quote only partly states this claim.

    Findingown data

    Among consumers of different caffeine-containing food groups, coffee consumers had the highest 95th percentile of caffeine consumption per day (up to 776 mg from coffee), followed by tea drinkers (up to 264 mg), energy drink consumers (up to 200 mg), and cola beverage consumers (up to 122 mg).

    “Considering caffeine intake in consumers of the different caffeine-containing food groups, coffee consumers had the highest 95 th percentile of caffeine consumption per day (up to 776 mg of caffeine from coffee), followed by tea drinkers (up to 264 mg of caffeine from tea),”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    When considering only days with consumption of different food categories, the 95th percentile of caffeine intake for children aged 3 to 10 years from coffee provided the highest estimate (15 mg/kg bw per day), followed by chocolate (7.7 mg/kg bw per day).

    “When considering only days with consumption of the different food categories, the 95 th percentile of caffeine intake from coffee provided the highest estimate (15 mg/kg bw per day), followed by chocolate (7.7 mg/kg bw per day) (Appendix C).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    For pregnant women in Latvia, mean daily caffeine intake from all sources was 109 mg and 95th percentile was 206 mg per day.

    “The mean and the 95 th percentile of the daily caffeine intake from all sources were 109 mg and 206 mg per day, respectively (Appendix B).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    In only the UK and the Netherlands was a specific code for energy drinks available in the database.

    “In only the first two was a specific code for”
    Quote in the paperNot a substantial claim
  • May combine two claims. The quote only partly states this claim.

    Findingnone given

    Daily intake estimates for the elderly and very elderly are of similar magnitude to adults, with a tendency for lower 95th percentiles.

    “Daily intake estimates for the elderly and very elderly are of a similar magnitude, with a tendency for lower 95 th percentiles.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In these surveys, the prevalence of energy drink consumers was most often zero and never exceeded 1% in toddlers, children aged 3-10 years, the elderly, very elderly, lactating women and pregnant women.

    “In these surveys, the prevalence of”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).

    Findingnone given

    The prevalence of energy drink consumers among the 17 surveys introduced into the EFSA Comprehensive Database in 2014 using the FoodEx2 code for energy drinks was <10%.

    “The prevalence of”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    According to this survey, 47, 26, 13, 9 and 5% of adult energy drink consumers declared consuming one, two, three, four and five or more cans of energy drinks in relation to a single sport session.

    “According to this survey, 47, 26, 13, 9 and 5 % of this population declared that they consume one, two, three, four and five or more cans of”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims. The quote only partly states this claim.

    Findingcitation

    The EFSA energy drink report provides information about caffeine intakes by adolescents and adults from energy drinks on a single session, also in relation to a single session of physical exercise.

    “The EFSA”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The highest prevalences of energy drink consumers were observed in adolescents (9% in the Netherlands, 7% in the UK and 5% in Finland) and adults (8% in Ireland, 4% in the Netherlands and 3% in the UK).

    “The highest prevalences of”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In this survey, 48, 25, 13, 7 and 7% of adolescent energy drink consumers declared consuming one, two, three, four and five or more cans of energy drinks in relation to a single sport session.

    “In this survey, 48, 25, 13, 7 and 7 % of this population declared that they consume one, two, three, four and five or more cans of”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingnone given

    Data are particularly scarce for pregnant and lactating women, and absent regarding the consumption of caffeine-containing supplements.

    “Data are particularly scarce for pregnant and lactating women, and absent regarding the consumption of caffeine-containing supplements.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingnone given

    Among the individual studies, a positive association between habitual caffeinated coffee consumption and CVD risk has been reported only for CHD in 8 out of the 56 studies reviewed, only 6 of which had any type of adjustment for confounding variables.

    “Among the individual studies, a positive association between habitual caffeinated coffee consumption and CVD risk has been reported only for CHD (but not for stroke, AF or heart failure) in 8 out of the 56 studies reviewed, only 6 of which had any type of adjustment for confounding variables.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingreasoning

    Of the studies reporting a positive association, only two reported an increased risk of CHD associated with habitual coffee consumption of four or less cups per day, corresponding to about 400 mg per day of caffeine, which may be an underestimation of total caffeine intake.

    “Of these, only two reported an increased risk of CHD associated with habitual coffee consumption of four or less cups per day (one for three or more cups per day, one for three to four cups per day), corresponding to about 400 mg per day of caffeine, which may be an underestimation of total caffeine intake”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Findingown data

    For 6 out of 14 Member States, the estimates of the 95th percentile of daily caffeine intake from all sources exceed 3 mg/kg bw for children.

    “For 6 out of 14 Member States the estimates of the 95 th percentile of daily caffeine intake from all sources exceeds 3 mg/kg bw.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation

    For the 3 mg/kg bw dose, only 1 out of 42 pre-term infants showed tachycardia and jittering, and only tachycardia with no jittering was observed in 8 out of 45 infants at doses 100-fold higher (30 mg/kg bw).

    “For this dose, only 1 out of 42 pre-term infants showed tachycardia and jittering, and only tachycardia (with no jittering) was observed in 8 out of 45 infants at doses 100-fold higher (30 mg/kg bw).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Steer et al., 2003 source

      Not checked in the free run.

  • May combine two claims.

    Findingnone given

    The mean and the 95th percentile of the daily caffeine intakes from foods and beverages in the only survey available for pregnant women were 109 mg and 206 mg per day, respectively.

    “The mean and the 95 th percentile of the daily caffeine intakes from foods and beverages in the only survey available were 109 mg and 206 mg per day, respectively.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingnone given

    The surveys considered did not report on the consumption of caffeine from food supplements, and there are no data on the frequency and quantity of consumption of caffeine from this source in Europe in different subgroups of the population.

    “The Panel notes that the surveys considered did not report on the consumption of caffeine from food supplements, and that there are no data on the frequency and quantity of consumption of caffeine from this source in Europe in different subgroups of the population.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The mean and the 95th percentile of the daily caffeine intakes from food and beverages in the only survey available for lactating women were 31 mg and 97 mg per day, respectively, which are well below 200 mg.

    “The mean and the 95 th percentile of the daily caffeine intakes from food and beverages in the only survey available were 31 mg and 97 mg per day, respectively, which are well below 200 mg.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingnone given

    Only limited studies are available on the longer-term effects of caffeine on anxiety and behaviour in children and adolescents, and there is substantial uncertainty regarding longer-term effects of habitual caffeine consumption in this age group.

    “As only limited studies are available on the longer-term effects of caffeine on anxiety and behaviour in children and adolescents, there is substantial uncertainty regarding longer-term effects of habitual caffeine consumption in this age group.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingnone given

    The question of whether p-synephrine modifies the long-term effects of caffeine on the cardiovascular system has not been adequately investigated in humans, and therefore no conclusions could be drawn.

    “The Panel considers that the question of whether or not p-synephrine modifies the long-term effects of caffeine on the cardiovascular system has not been adequately investigated in humans, and therefore no conclusions could be drawn.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductreasoning

    The scientific assessment is based on human intervention and observational studies with adequate control for confounding variables, which have been conducted in healthy subjects at recruitment.

    “The scientific assessment is based on human intervention and observational studies with adequate control for confounding variables, which have been conducted in healthy subjects at recruitment.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    Estimates of the proportion of single days in which caffeine intake exceeds 3 mg/kg bw among all survey days using the EFSA Comprehensive Database were used as a conservative approximation.

    “Estimates of the proportion of single days in which caffeine intake exceeds 3 mg/kg bw among all survey days using the EFSA Comprehensive Database were used as a conservative approximation.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisenone given

    Overall, at EU level to date, caffeine has only been assessed in the context of energy drinks but the safety of overall caffeine intake, from all sources, and acceptable use levels has not yet been assessed.

    “Overall, at EU level to date, caffeine has only been assessed in the context of energy drinks but the safety of overall caffeine intake, from all sources, and acceptable use levels has not yet been assessed.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    Whenever available, human intervention studies and prospective cohort studies have been preferred over case-control and cross-sectional studies because of the lower risk of reverse causality and recall bias.

    “Whenever available, human intervention studies and prospective cohort studies have been preferred over case-control and cross-sectional studies because of the lower risk of reverse causality and recall bias.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    Case reports of adverse events have not been considered for the scientific assessment.

    “Case reports of adverse events have not been considered for the scientific assessment.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Interpretationreasoning

    Caffeine is not an essential nutrient, and thus ULs cannot be derived.

    “However, caffeine is not an essential nutrient, and thus ULs cannot be derived.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Caffeine is not an essential nutrient.
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims. The quote only partly states this claim.

    Interpretationreasoning

    Other common constituents of energy drinks at doses commonly present and/or moderate habitual alcohol consumption would not affect the safety of habitual caffeine consumption up to 400 mg per day.

    “Other common constituents of”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationreasoning

    This approach is rather conservative in relation to the effects of caffeine on the cardiovascular system, but the limited studies available regarding the longer-term effects of caffeine on anxiety and behaviour in children and adolescents support the proposed caffeine intake level of no safety concern.

    “This approach is rather conservative in relation to the effects of caffeine on the cardiovascular system, but the limited studies available regarding the longer-term effects of caffeine on anxiety and behaviour in children and adolescents support the proposed caffeine intake level of no safety concern.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Interpretationreasoning

    Advice on the safe/recommended timing of caffeine consumption prior to physical activity cannot be provided by the derivation of an UL.

    “In addition, advice on the safe/recommended timing of caffeine consumption prior to physical activity cannot be provided by the derivation of an UL.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Caffeine is not an essential nutrient.
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Interpretationreasoning

    As caffeine clearance in children and adolescents is at least that of adults, the same levels of no safety concern derived for adults (i.e. 5.7 mg/kg bw) may also apply to children, unless there are data showing a higher sensitivity to the effects of caffeine in this age group.

    “As caffeine clearance in children and adolescents is at least that of adults, the same levels of no safety concern derived for adults (i.e.5.7 mg/kg bw) may also apply to children, unless there are data showing a higher sensitivity to the effects of caffeine in this age group (i.e.difference in pharmacodynamics).”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Caffeine clearance in children and adolescents is at least that of adults.
    • Rests on an assumption: No data show a higher sensitivity to the effects of caffeine in children and adolescents (i.e., difference in pharmacodynamics).
  • May combine two claims.

    Study design and conductnone given

    The 17 surveys from 11 Member States added in 2014 used the FoodEx2 code classification, which allows accurate reporting of 'energy drink' consumption.

    “The 17 surveys from 11 Member States added in 2014 used the FoodEx2 code classification, which allows accurate reporting of “energy drink” consumption (Appendix A).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductcitation

    The 95th percentile estimates obtained from dietary surveys and age classes with fewer than 60 subjects may not be statistically robust and consequently were not considered in the table.

    “(a): The 95 th percentile estimates obtained from dietary surveys and age classes with fewer than 60 subjects may not be statistically robust (EFSA, 2011b) and consequently were not considered in this table (“-”).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites EFSA, 2011b

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    Owing to the differences in the methods used for data collection, direct country-to-country comparisons must be taken with caution.

    “Owing to the differences in the methods used for data collection, direct country-to-country comparisons must be taken with caution.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductreasoning

    A 'night out', 'study session' or 'sport session' could last more than two hours, and it is not possible from the report to precisely define the time frame covered by a 'single session'.

    “The Panel notes, however, that a “night out”, “study session” or “sport session” could last more than two hours, and it is not possible from the report to precisely define the time frame covered by a “single session”.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductreasoning

    The 95th percentiles of caffeine intake on a single day were calculated to gather information on days of particularly high caffeine consumption, but these do not provide information about the proportion of subjects with high caffeine consumption days.

    “The 95 th percentiles of caffeine intake on a single day have been calculated to gather information on days of particularly high caffeine consumption, but these do not provide information about the proportion of subjects with high caffeine consumption days.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Systematic reviews and meta-analysis have been used to summarise the scientific evidence whenever available.

    “Systematic reviews and meta-analysis have been used to summarise the scientific evidence whenever available.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Study design and conductreasoning

    It is also possible that some of the brands of cocoa-beverage preparation powder consumed in particular by children are decaffeinated.

    “It is also possible that some of them are decaffeinated.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductreasoning

    The study could be used to calculate caffeine intakes from 'energy drinks' in a 'single session', either alone or in combination with physical exercise, but not to calculate total caffeine intakes from all sources or from sources other than 'energy drinks'.

    “Therefore, the Panel considered that this study could be used to calculate caffeine intakes from “energy drinks” in a “single session”, either alone or in combination with physical exercise, but not to calculate total caffeine intakes from all sources or from sources other than “energy drinks”.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Food frequency questionnaires specifically developed to assess consumption of specific foods tend to overestimate consumption of such foods.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    Owing to personal choices, individual consumers might have coffee beverages with lower or higher caffeine levels than those used in the present assessment.

    “Owing to personal choices, individual consumers might therefore have coffee beverages with lower or higher caffeine levels than those used in the present assessment.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    It is not possible to exclude that some of the brands of cocoa-beverage preparation powder consumed in particular by children contain lower levels of caffeine than those used in the present assessment.

    “However, it is not possible to exclude that some of the brands of cocoa-beverage preparation powder consumed in particular by children contain lower levels of caffeine than those used in the present assessment.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductnone given

    The EFSA Comprehensive European Food Consumption Database was used to calculate caffeine intake from food and beverages; it contains data from 39 surveys in 22 different European countries for a total of 66,531 participants.

    “The EFSA Comprehensive European Food Consumption Database was used to calculate caffeine intake from food and beverages.It contains data from 39 surveys in 22 different European countries for a total of 66 531 participants.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductcitation

    The study provides useful information about the prevalence of 'energy drink' consumption in Europe, the number of 'energy drinks' (and the amount of their constituents, including caffeine) consumed in a 'single session' and the prevalence of 'energy drink' consumption in combination with physical activity.

    “The Panel notes that this study provides useful information about the prevalence of “energy drink” consumption in Europe, the number of “energy drinks” (and the amount of their constituents, including caffeine) consumed in a “single session” and the prevalence of “energy drink” consumption in combination with physical activity.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    The study contains information about the frequency of consumption of 'energy drinks' in combination with alcohol, but not on the amount of alcohol consumed in combination with 'energy drinks'.

    “(iii) the study contains information about the frequency of consumption of “energy drinks” in combination with alcohol, but not on the amount of alcohol consumed in combination with “energy drinks”.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    The EFSA report on energy drinks was used to calculate caffeine intakes from energy drinks in a single session in adults, either alone or in combination with physical exercise.

    “The EFSA report on energy drinks was used to calculate caffeine intakes from”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationreasoning

    Although the time covered by the term single session is imprecise, these data give an idea of the amounts of caffeine from energy drinks consumed as a single dose or during short periods of time.

    “Although the time covered by the term”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    In humans, caffeine is rapidly (tmax 30-120 minutes) and completely absorbed after oral intake.

    “In humans, caffeine is rapidly (t max 30-120 minutes) and completely absorbed after oral intake (Blanchard and Sawers, 1983).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Blanchard and Sawers, 1983 source

      Not checked in the free run.

  • May combine two claims.

    Premisereasoning

    The Panel notes that high total caffeine intakes (500-750 mg per day) were used in the repeated-dose studies, that lower repeated doses of caffeine (<250 mg) have not been tested, and that the four-hour interval between doses is about one half-life and is likely to induce an increase in plasma caffeine concentrations throughout the day.

    “The Panel notes the high total caffeine intakes used in these studies (500-750 mg per day), that lower repeated doses of caffeine (< 250 mg) have not been tested and that the time between doses (four hours), about one half-life, is likely to induce an increase in plasma caffeine concentrations throughout the day.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    Single caffeine doses of about 200-300 mg induced a mean increase in systolic blood pressure of about 3-8 mmHg and in diastolic blood pressure of about 4-6 mmHg, with high inter-individual variability.

    “which induced a mean increase in SBP of about 3-8 mmHg and in DBP of about 4-6 mmHg, with high inter-individual variability.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationnone given

    The EFSA Comprehensive Database is useful to gather data on daily caffeine intakes from all sources from unselected populations and population subgroups, as well as on the contribution of different food groups to total caffeine intakes.

    “The EFSA Comprehensive Database is useful to gather data on daily caffeine intakes from all sources from unselected populations and population subgroups, as well as on the contribution of different food groups to total caffeine intakes.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    In Lane et al. 2002, compared with placebo, caffeine significantly raised average systolic blood pressure through the entire day by about 4 mmHg and diastolic blood pressure by about 3 mmHg, while heart rate decreased by 2 bpm.

    “Compared with placebo, caffeine significantly raised average SBP through the entire day by about 4 mmHg and DBP by about 3 mmHg, whereas heart rate (HR) decreased by 2 bpm, with no significant interaction between treatment and location (at work, at home).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Lane et al., 2002

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Souza et al. 2014 reported a significant decrease in systolic blood pressure and mean arterial blood pressure and a significant increase in heart rate after exercise with caffeine and placebo; diastolic blood pressure and heart rate (but not systolic blood pressure) were significantly higher at rest with caffeine than with placebo, as was peripheral vascular resistance in the nine hours post

    “Souza et al. (2014) reported a significant decrease in SBP and MABP and a significant increase in HR after exercise with caffeine and placebo.DPB and HR (but not SPB) were significantly higher at rest with caffeine than with placebo, as was peripheral vascular resistance (SBP, DBP, HR, stroke volume or cardiac output) in the nine hours post exercise.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Souza et al., 2014 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Bischoff 2013 pre-study, a significant increase in systolic blood pressure (by about 7-8 mmHg) was reported following consumption of the sports drink plus caffeine in both preliminary tests, whereas consumption of the other beverages did not increase systolic blood pressure significantly, and no significant changes in diastolic blood pressure were noted.

    “A significant increase in SBP (by about 7-8 mmHg) was reported following consumption of the sports drink plus caffeine in both preliminary tests, whereas consumption of the other beverages did not increase SBP significantly.No significant changes in DBP were noted.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Bischoff, 2013

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    All available studies in healthy individuals report a significant adverse effect of caffeine at doses of 100-250 mg on one or more measures of arterial compliance, denoting an increase in arterial stiffness, accompanied by a simultaneous increase in one or more measures of blood pressure.

    “All studies available in healthy individuals (Mahmud and Feely, 2001;Vlachopoulos et al., 2003Vlachopoulos et al., , 2006;;Hartley et al., 2004;Karatzis et al., 2005;Swampillai et al., 2006) reported a significant adverse effect of caffeine (in supplements, coffee or tea) at doses of 100-250 mg on one or more measures of arterial compliance”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Mahmud and Feely, 2001 source

      Not checked in the free run.

    • cites Vlachopoulos et al., 2003 source

      Not checked in the free run.

    • cites Hartley et al., 2004 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given

    Paraxanthine, theophylline and theobromine are further metabolised and then excreted in the urine.

    “Paraxanthine, theophylline and theobromine are further metabolised and then excreted in the urine.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Significant increases in systolic and diastolic blood pressure were reported for a combination of 5.5 mg p-synephrine and 5.7 mg octopamine and caffeine (239.2 mg), and a significant increase in diastolic blood pressure but not systolic blood pressure was observed with 21 mg p-synephrine and 304 mg caffeine.

    “Significant increases in SBP and DBP were also reported for a combination of 5.5 mg p-synephrine and 5.7 mg octopamine and caffeine (239.2 mg), and a significant increase in DBP, but not in SPB, was observed with 21 mg p-synephrine and 304 mg caffeine.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Stohs et al., 2012 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    The Panel considers that the available resistance-exercise studies suggest an additive effect of caffeine and resistance training on blood pressure during exercise, and that caffeine could attenuate the decrease in blood pressure observed after resistance training.

    “The Panel considers that, although these studies have small sample sizes and are difficult to compare, they suggest an additive effect of caffeine and resistance training on BP during exercise, and that caffeine could attenuate the decrease in BP observed after resistance training.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Higher CYP1A2 activity was found in smokers and men than in non-smokers and women, respectively.

    “These authors also found a higher CYP1A2 activity in smokers and men than in non-smokers and women, respectively.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Rasmussen et al., 2002 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    The prevalence of energy drink consumers in the EFSA energy drink report survey is considerably higher than that calculated from the EFSA's Comprehensive Database, mainly because of differences in the definition of consumers and in the methodology used to retrieve consumption data.

    “The Panel notes that the prevalence of”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Astorino et al. 2007 found that systolic blood pressure, heart rate and rate-pressure product (but not diastolic blood pressure) significantly increased during exercise with caffeine and placebo and were significantly higher before and during exercise with caffeine than with placebo, with no time by treatment interaction, suggesting an additive but not synergistic effect of caffeine and exercise.

    “In the study by Astorino et al. (2007), SBP, HR and ratepressure product (but not DBP) significantly increased during exercise with caffeine and placebo and were significantly higher before and during exercise with caffeine than with placebo, but no time by treatment interaction was observed, suggesting an additive (but not synergistic) effect of caffeine and exercise on BP.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Astorino et al., 2007 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Astorino et al. 2013 found that systolic blood pressure significantly increased during all exercise protocols and significantly decreased post exercise with caffeine and placebo; systolic blood pressure was significantly higher before and two hours after exercise with caffeine than with placebo, whereas heart rate and diastolic blood pressure were not different; systolic blood pressure was higher,

    “In the study by Astorino et al. (2013), in which four resistance exercise protocols were tested, SBP significantly increased during all exercise protocols and significantly decreased post exercise with caffeine and placebo.SBP was significantly higher before and two hours after exercise with caffeine than with placebo, whereas HR and DBP were not different between treatments.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Astorino et al., 2013 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    The effect of caffeine on blood pressure was observed at single doses ranging from 80 to 300 mg, although most studies tested doses of about 200-300 mg.

    “The effect was observed at single doses of caffeine ranging from 80 to 300 mg, although most studies tested doses of about 200-300 mg”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    Such differences do not allow direct between-country comparisons, and thus ranges of means and 95th percentiles across surveys should be interpreted with caution.

    “Such differences do not allow direct between-country comparisons, and thus ranges of means and 95 th percentiles across surveys should be interpreted with caution.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Compared with decaffeinated coffee, caffeinated coffee significantly increases systolic blood pressure (130 mg caffeine) and diastolic blood pressure (80 and 130 mg caffeine), and decreases endothelium-dependent flow-mediated dilatation in habitual moderate coffee consumers after 12-24 hours' caffeine withdrawal.

    “compared with decaffeinated coffee, caffeinated coffee has been reported to significantly increase SBP (130 mg caffeine) and DBP (80 and 130 mg caffeine), as well as to decrease endothelium-dependent flow-mediated dilatation (FMD) in habitual moderate coffee consumers after 12-24 hours' caffeine withdrawal”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Papamichael et al., 2005 source

      Not checked in the free run.

    • cites Buscemi et al., 2010 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    Repeated doses of 250 mg caffeine taken four hours apart may induce a significant increase in daytime blood pressure, blood pressure remains significantly elevated up to 9-12 hours after consumption of the last dose, and the effect depends on habitual caffeine consumption and is mostly observed after caffeine withdrawal.

    “These studies suggest that repeated doses of 250 mg caffeine taken four hours apart may induce a significant increase in daytime BP, that BP remains significantly elevated up to 9-12 hours after consumption of the last dose and that the effect, which depends on habitual caffeine consumption, is mostly observed after caffeine withdrawal.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Health concerns expressed by national and international risk assessment bodies in relation to caffeine mostly refer to its effects on pregnancy outcomes, the cardiovascular system and the CNS.

    “As indicated in the background provided by the European Commission and in Section 2.4 of this opinion, the health concerns expressed by national and international risk assessment bodies in relation to caffeine mostly refer to its effects on pregnancy outcomes, the cardiovascular system and the CNS.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    The present opinion considers primarily human data and addresses specific subgroups of the population, such as pregnant and lactating women, children and subjects performing physical exercise.

    “As in previous risk assessments by, for example, the SCF and EU Member State Committees, the present opinion considers primarily human data and addresses specific subgroups of the population, such as pregnant and lactating women, children and subjects performing physical exercise.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisenone given

    Concerns were also raised with respect to caffeine in energy drinks, particularly if combined with alcohol, and to food supplements containing caffeine and p-synephrine.

    “Concerns were also raised with respect to caffeine in so-called”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given

    Other primary metabolites of caffeine are theophylline and theobromine.

    “Other primary metabolites are theophylline and theobromine.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The homozygote AA genotype has been considered by some authors as a fast metaboliser, while AC and CC genotypes were considered slow metabolisers.

    “The homozygote AA genotype has been considered by some authors as a”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Caffeine significantly raises systolic and diastolic blood pressure in all hypertension-risk groups of men, with the strongest response among diagnosed hypertensive men (mean systolic increase of 10 mmHg) and a change 1.5 times greater than in men with optimal blood pressure.

    “Caffeine significantly raised both SBP and DBP in all groups.However, the strongest response to caffeine was observed among diagnosed men (mean increase in SBP of 10 mmHg), followed by the stage 1 and high-normal groups and then by the normal and optimal groups, with a change 1.5 times greater in diagnosed hypertensive individuals than in the group with optimal BP.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Hartley et al., 2000 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Namdar et al. 2006, under hypoxia, caffeine significantly increased resting myocardial blood flow (1.71 ± 0.41 versus 2.22 ± 0.49 mL/min per g tissue; p < 0.001) and significantly decreased exercise-induced hyperaemic myocardial blood flow (5.15 ± 0.79 versus 3.98 ± 0.83 mL/min per g tissue; p < 0.005), leading to a decrease in myocardial flow reserve of 39% (3.13 ± 0.60 to 1.87 ± 0.45; p < 0.

    “Caffeine significantly increased resting MBF (1.71 ± 0.41 mL/min per g tissue versus 2.22 ± 0.49 mL/min per g tissue; p < 0.001) and significantly decreased exercise-induced hyperaemic MBF (5.15 ± 0.79 mL/min per g tissue versus 3.98 ± 0.83 mL/min per g tissue; p < 0.005), leading to a decrease in MFR of 39 % (3.13 ± 0.60 to 1.87 ± 0.45; p < 0.005).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Namdar et al., 2006 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In the Stroke Onset Study, there was no apparent increase in risk in the hour following consumption of caffeinated tea (relative risk 0.9; 95% CI 0.4-2.0; p = 0.85) or cola (relative risk 1.0; 95% CI 0.4-2.4; p = 0.95).

    “There was no apparent increase in risk in the hour following consumption of caffeinated tea (RR = 0.9; 95 % CI = 0.4-2.0;p = 0.85) or cola (RR = 1.0; 95 % CI = 0.4-2.4;p = 0.95)”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Mostofsky et al., 2010a, b

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In a study of healthy trained male cyclists, compared with placebo, caffeine significantly increased core rectal temperature during exercise by up to about 0.5 degrees Celsius, whereas it had no significant effect on skin temperature, heart rate, loss of body mass or sweat rate.

    “Compared with placebo, caffeine significantly increased core (rectal) temperature during exercise by up to about 0.5 C, whereas it had no significant effect on skin temperature, heart rate, loss of body mass or sweat rate.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Roelands et al., 2011 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationreasoning

    Although not formally tested, the Panel considers that changes in blood pressure and myocardial blood flow induced by repeated intakes of caffeine at doses and time intervals which would not exceed the maximum plasma concentrations achieved with a single dose of 200 mg of caffeine would also be of low clinical relevance for healthy individuals in the general population under normal environmental条件

    “Although not formally tested, the Panel considers that changes in BP and MBF induced by repeated intakes of caffeine at doses and time intervals which would not exceed the maximum plasma concentrations achieved with a single dose of 200 mg of caffeine would also be of low clinical relevance for healthy individuals in the general population under normal environmental conditions.”
    Quote in the paperNot a substantial claim
  • The quote only partly states this claim.

    Premisecitation

    In healthy males who were low habitual caffeine consumers (<100 mg/day), 5 mg/kg body weight of caffeine consumed daily for four consecutive days did not lead to significant changes in hydration measures compared with placebo.

    “Similar results were obtained in two studies with a similar design conduced in healthy males, in which 5 mg/kg bw of caffeine were consumed daily for four consecutive days by low habitual caffeine consumers (< 100 mg/day) (Silva et al., 2013)”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Silva et al., 2013 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In a study of nonhabitual caffeine consumers, after caffeine consumption, sweating rate was significantly higher and the onset of sweating was significantly delayed during exercise.

    “After caffeine consumption, sweating rate was significantly higher and the onset of sweating was significantly delayed during exercise.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Kim et al., 2011 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Baylin et al. 2006, patients with light or occasional coffee intake (up to one cup per day; n = 66) had a relative risk of myocardial infarction in the hour after taking coffee of 4.14 (95% CI 2.03-8.42), those with moderate consumption (two to three cups per day; n = 280) had a relative risk of 1.60 (95% CI 1.16-2.21), and heavy drinkers (four or more cups per day; n = 120) had a relative risk

    “patients with light/occasional intake of coffee (up to one cup per day; n = 66) had a RR of MI in the hour after taking coffee of 4.14 (95 % CI = 2.03-8.42),those with moderate consumption of coffee (two to three cups per day; n = 280) had a RR of 1.60 (95 % CI = 1.16-2.21),and heavy drinkers (four or more cups per day; n = 120) had a RR of 1.06 (95 % CI = 0.69-1.63;p = 0.006, test for interaction”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Baylin et al., 2006 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    The effect of caffeine on blood pressure may be more pronounced in subjects with high blood pressure and after caffeine withdrawal.

    “The effect may be more pronounced in subjects with high BP and after caffeine withdrawal.”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Premisecitation

    In a study of male recreational runners, no significant differences in core temperature were observed between the caffeine and placebo conditions.

    “No significant differences in core temperature were observed between the caffeine and placebo conditions.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ping et al., 2010

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    Caffeine antagonises the vasodilator effect of adenosine and other A2A receptor agonists in the coronary arteries in a dose-dependent manner, and this effect leads to a reduction of myocardial blood flow and myocardial flow reserve during intense physical exercise, primarily in subjects with coronary artery disease, but also in healthy subjects to some degree.

    “The Panel notes that caffeine antagonises the vasodilator effect of adenosine and other A 2A receptor agonists in the coronary arteries in a dose-dependent manner and this effect leads to a reduction of MBF and MFR during intense physical exercise, primarily in subjects with CAD, but also in healthy subjects to some degree.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Caffeine is a non-selective competitive A2A receptor antagonist that counteracts the vasodilator effect of adenosine and other A2A receptor agonists in the coronary arteries, where the density of such receptors is particularly high.
    • Rests on an assumption: The cardiac hyperaemic response to physical exercise is primarily mediated by endogenous production of adenosine by myocytes as a consequence of hypoxia, which induces vasodilation of the coronary arteries.
  • May combine two claims.

    Premisecitation

    Namdar et al. 2009 found that resting myocardial blood flow was not significantly affected by caffeine in either patients with coronary artery disease or healthy controls; exercise-induced hyperaemic myocardial blood flow and myocardial flow reserve significantly decreased 50 minutes after caffeine ingestion; myocardial flow reserve decreased in healthy subjects by 14% (p < 0.05) and in coronary-

    “Resting MBF was not significantly affected by caffeine consumption in either group.Exercise-induced hyperaemic MBF and MFR significantly decreased 50 minutes after caffeine ingestion compared with baseline measurements without caffeine.MFR significantly decreased in healthy subjects by 14 % (p < 0.05) and in CAD patients by 18 % (p < 0.05) in remote segments and by 25 % (p < 0.01) in stenotic”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Namdar et al., 2009 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In the Stroke Onset Study, the risk of stroke onset was 2.3-fold higher (95% CI 1.4-4.0; p = 0.002) within one hour of stroke and the relative risk was 1.6 (95% CI 1.0-2.5; p = 0.05) in the second hour after alcohol use compared with periods of non-use; the relative risk returned to baseline thereafter.

    “The risk of stroke onset was 2.3-fold higher (95 % CI = 1.4-4.0;p = 0.002) within one hour of stroke and RR was 1.6 (95 % CI = 1.0-2.5;p = 0.05) in the second hour after alcohol use compared with periods of non-use.The RR returned to baseline thereafter.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Mostofsky et al., 2010a, b

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Selb Semerl and Selb 2004, the estimated relative risk of dying within one hour after coffee consumption was 1.73 (95% CI 1.13-2.65) and was 3.00 (95% CI 1.61-5.68) within two hours after alcohol consumption.

    “The estimated RR of dying within one hour after coffee consumption was 1.73 (95 % CI = 1.13-2.65)and was 3.00 (95 % CI = 1.61-5.68)within two hours after alcohol consumption.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Selb Semerl and Selb, 2004

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Available data suggest that blood pressure generally increases 30 minutes after caffeine consumption, reaches a peak after 60-90 minutes and returns to baseline after about two to four hours, which is consistent with the pharmacokinetics of caffeine.

    “The available data suggest that BP generally increases 30 minutes after caffeine consumption, reaches a peak after 60-90 minutes and returns to baseline after about two to four hours, which is consistent with the pharmacokinetics of caffeine.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In Baylin et al. 2006, usual coffee intake was the only variable that significantly modified the risk; age, sex, physical activity, history of diabetes, hypercholesterolaemia, hypertension, smoking status or having at least three or less than three risk factors for disease did not significantly modify the risk.

    “This was the only variable that significantly modified the risk; age, sex or physical activity, history of diabetes, hypercholesterolaemia, hypertension, smoking status or having at least three (n = 101) or less than three of these risk factors for disease did not significantly modify the risk.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Baylin et al., 2006 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Gaemperli et al. 2008 found that myocardial blood flow was not significantly different between caffeine and placebo at rest (1.13 ± 0.04 versus 1.06 ± 0.05 mL/min per g) or under stress (2.98 ± 0.14 versus 3.05 ± 0.14 mL/min per g), and there was no difference in myocardial flow reserve (2.75 ± 0.16 versus 2.97 ± 0.16 mL/min per g); the data show with one-sided 95% confidence that any myocardial

    “The MBF (mean ± standard error of the mean (SEM)) was not significantly different between caffeine and placebo at rest (1.13 ± 0.04 mL/min per g versus 1.06 ± 0.05 mL/min per g) or under stress (2.98 ± 0.14 mL/min per g versus 3.05 ± 0.14 mL/min per g).There was no difference in MFR between caffeine and placebo (2.75 ± 0.16 mL/min per g versus 2.97 ± 0.16 mL/min per g).The data show with one-sided”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Gaemperli et al., 2008 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In a study of healthy men, compared with placebo, single doses of 9 mg/kg body weight caffeine consumed after four days of caffeine abstinence increased core rectal body temperature by 0.20-0.30 degrees Celsius, but not skin temperature.

    “Compared with placebo, single doses of 9 mg/kg bw caffeine consumed after four days of caffeine abstinence also increased core (rectal) body temperature (by 0.20-0.30C), but not skin temperature, in 10 healthy men”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Cheuvront et al., 2009 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In a study of cyclists, rectal temperature in the caffeine plus carbohydrate-electrolyte trials was significantly higher than in placebo trials by 0.19 to 0.29 degrees Celsius after 60 minutes, but was significantly higher than in carbohydrate-electrolyte trials only in the last 15 minutes.

    “Rectal temperature in the CAF + CE trials was significantly higher than in the placebo trials (by 0.19 to 0.29 C) after 60 minutes, but was significantly higher than in the CE trials only in the last 15 minutes”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Millard-Stafford et al., 2007

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Tejani et al. 2014 showed that doses of caffeine of 200 mg and 400 mg significantly decreased the number of cardiac segments with reversible vascularisation defects, suggesting that caffeine at doses of 200 mg or greater could significantly counteract the vasodilator effect of regadenoson in the coronary arteries in patients with coronary artery disease.

    “a similar study using regadenoson stress-single-photon emission computed tomography (SPECT) MPI in patients with CAD showed that doses of caffeine of 200 mg and 400 mg significantly decreased the number of cardiac segments with reversible vascularisation defects, suggesting that caffeine at doses of 200 mg or greater could significantly counteract the vasodilator effect of regadenoson in the”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Tejani et al., 2014 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Single doses of caffeine of about 100-600 mg consumed prior to exercise did not lead to a significant increase in urinary volume or a significantly different water retention during dehydration, and did not induce adverse water-electrolyte imbalances compared with water or placebo, particularly in habitual caffeine consumers.

    “Single doses of caffeine of about 100-600 mg consumed prior to exercise, however, did not lead to a significant increase in urinary volume or a significantly different water retention during dehydration, and did not induce adverse water-electrolyte imbalances compared with water or placebo, particularly in habitual caffeine consumers (Armstrong, 2002).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Armstrong, 2002 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Baylin et al. 2006, the relative risk after coffee intake was not significantly increased when two or three hours were selected as the hazard period, suggesting that the risk dropped to basal conditions between one and two hours after drinking coffee.

    “The RR after coffee intake was not significantly increased when two or three hours were selected as the hazard period, suggesting that the risk dropped to basal conditions between one and two hours after drinking coffee.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Baylin et al., 2006 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    Repeated doses of caffeine (250 mg) taken four hours apart also induce an increase in blood pressure (of about 3-4 mmHg) which may last up to 9-12 hours, particularly after caffeine withdrawal.

    “The Panel also notes that repeated doses of caffeine (250 mg) taken four hours apart also induce an increase in BP (of about 3-4 mmHg) which may last up to 9-12 hours, particularly after caffeine withdrawal.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.

    Premisenone given

    The Panel notes that the effect of higher doses of caffeine on coronary flow reserve has not been tested.

    “The Panel notes that the effect of higher doses of caffeine has not been tested.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    In the Stroke Onset Study, the association between ischaemic stroke in the hour after coffee consumption was apparent only among those consuming at most one cup per day but not for patients who consumed coffee more regularly (p for trend = 0.002).

    “The association between ischaemic stroke in the hour after coffee consumption was apparent only among those consuming at most one cup per day but not for patients who consumed coffee more regularly (p for trend = 0.002).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Mostofsky et al., 2010a, b

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In a study using the same caffeine dose, mean body temperature was significantly higher by 0.27 degrees Celsius one hour after caffeine consumption than with placebo only at the beginning of exercise, whereas no differences between caffeine and placebo were observed with respect to core, skin or mean temperature during exercise.

    “Conversely, in another study using the same caffeine dose, mean body temperature was significantly higher (by 0.27 C) one hour after caffeine consumption than with placebo only at the beginning of the exercise (cycling for 30 minutes at 50 % of VO 2peak in a 40 °C and 25 % relative humidity environment), whereas no differences between caffeine and placebo were observed with respect to core, skin”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ely et al., 2011 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationnone given

    Children appear to develop tolerance to the central effects of caffeine at high habitual intakes (>300 mg per day) and show withdrawal symptoms.

    “Children appear to develop tolerance to the central effects of caffeine at high habitual intakes (> 300 mg per day) and show withdrawal symptoms.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    In Jee et al. (1999), overall pooled estimates of treatment effect associated with coffee drinking were 2.4 mmHg (95% CI 1.0-3.7) for SBP and 1.2 mmHg (95% CI 0.4-2.1) for DBP.

    “The overall pooled estimates of treatment effect associated with coffee drinking were 2.4 mmHg (95 % CI = 1.0-3.7 mmHg) for SBP and 1.2 mmHg for DBP (95 % CI = 0.4-2.1 mmHg).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Jee et al., 1999 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    No significant differences in self-rated anxiety or investigator-rated items of behaviour were found between placebo and caffeine at any dose.

    “No significant differences in self-rated anxiety or investigatorrated items of behaviour were found between placebo and caffeine at any dose.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Elkins et al., 1981 source

      Not checked in the free run.

    • cites Rapoport et al., 1981b

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In a human intervention study, caffeine significantly increased urinary output and natriuresis, whereas taurine had no effect on either of these outcomes and did not appear to modify the diuretic effects of caffeine when administered simultaneously.

    “Caffeine significantly increased urinary output and natriuresis, whereas taurine had no effect on either of these outcomes and did not appear to modify the diuretic effects of caffeine when administered simultaneously.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Riesenhuber et al., 2006 source

      Not checked in the free run.

  • May combine two claims.

    Premiseown data

    Caffeine significantly increased SBP and DBP in studies with a majority of women (n=8), but not in those with a majority of men (n=17).

    “Caffeine significantly increased SBP and DBP in studies with a majority of women (n = 8), but not in those with a majority of men (n = 17).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Noordzij et al., 2005 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Scores for feeling nervous or jittery were significantly higher for the 3 mg/kg body weight dose than for placebo, and for the 10 mg/kg body weight dose than for the 3 mg/kg body weight dose.

    “Scores for this side effect were significantly higher for the 3 mg/kg bw dose than for placebo, and for the 10 mg/kg bw dose than for the 3 mg/kg bw dose.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Elkins et al., 1981 source

      Not checked in the free run.

    • cites Rapoport et al., 1981b

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In a study of children, caffeine intake was not significantly associated with any measures of self-reported anxiety, whereas a significant linear association was reported between caffeine concentrations in saliva and the anxiety state item in the VAA-R scale only.

    “Caffeine intake was not significantly associated with any of these measures of self-reported anxiety, whereas a significant linear association was reported between caffeine concentrations in saliva and the anxiety state item in the VAA-R scale only.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Bernstein et al., 1994 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationnone given

    Higher intakes of caffeine (10 mg/kg body weight per day) may increase anxiety and adversely affect behaviour and sleep in habitual low caffeine consumers.

    “whereas higher intakes (10 mg/kg bw per day) may increase anxiety and adversely affect behaviour and sleep in habitual low caffeine consumers.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationcitation

    The Panel notes that the Noordzij et al. (2005) meta-analysis shows a sustained BP-raising effect of continuous (≥7 days) caffeine consumption at doses of about 400 mg/day, but not at lower doses.

    “The Panel notes that this metaanalysis shows a sustained BP-raising effect of continuous (≥ 7 days) caffeine consumption at doses of about 400 mg per day, but not at lower doses.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Noordzij et al., 2005 source

      Not checked in the free run.

  • May combine two claims.

    Study design and conductreasoning

    The Panel notes the scarcity of studies available, the low number of children enrolled, and the heterogeneity of the studies regarding testing conditions, which hampers the comparability of the results.

    “However, the Panel also notes the scarcity of studies available and the low number of children enrolled, as well as the heterogeneity of the studies regarding the testing conditions (e.g. with respect to the tools used to assess anxiety and behavioural changes, and to the caffeine status before testing), which hampers the comparability of the results.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In Noordzij et al. (2005), after excluding nine coffee trials with an open design, changes in SBP were 2.81 mmHg (95% CI 1.08-4.53) and in DBP were 1.17 mmHg (95% CI 0.54-1.81); HR did not change significantly.

    “After excluding nine coffee trials with an open design, changes in SBP were 2.81 mmHg (95 % CI = 1.08-4.53mmHg) and in DBP were 1.17 mmHg (95 % CI = 0.54-1.81mmHg).HR did not change significantly.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Noordzij et al., 2005 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Jee et al. (1999), duration of run-in and coffee dose significantly modified the effect of coffee on BP; studies with shorter run-ins and the highest doses of coffee showed the biggest effect on BP.

    “Duration of run-in and coffee dose significantly modified the effect of coffee on BP.Studies with shorter run-ins and the highest doses of coffee showed the biggest effect on BP.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Jee et al., 1999 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Noordzij et al. (2005) stratified analyses, type of intervention, sex and caffeine dose significantly affected changes in BP, whereas age, baseline BP, baseline caffeine intake and study duration did not.

    “the type of intervention, sex and caffeine dose significantly affected changes in BP, whereas age, baseline BP, baseline caffeine intake and study duration (< 6 weeks or ≥ 6 weeks) did not.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Noordzij et al., 2005 source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Interpretationreasoning

    The Panel considers that intravenous route of administration is not appropriate to investigate the effects of oral caffeine consumption on anxiety.

    “The Panel considers that this route of administration is not appropriate to investigate the effects of oral caffeine consumption on anxiety.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Nickell and Uhde (1994)

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In the meta-analysis by Noordzij et al. (2005), combining all caffeine and coffee studies, SBP significantly increased by 2.04 mmHg (95% CI 1.10-2.99) and DBP significantly increased by 0.73 mmHg (95% CI 0.14-1.31).

    “Combining all caffeine and coffee studies, SBP significantly increased by 2.04 mmHg (95 % CI = 1.10-2.99mmHg) and DBP significantly increased by 0.73 mmHg (95 % CI = 0.14-1.31mmHg).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Noordzij et al., 2005 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    In children, single doses of caffeine of 3 mg/kg body weight do not appear to induce anxiety or behavioural changes, although inter-individual variability in relation to habitual caffeine intakes has not been studied.

    “In children, similar single doses of caffeine on a weight basis (3 mg/kg bw) do not appear to induce anxiety or behavioural changes, although inter-individual variability in relation to habitual caffeine intakes has not been studied.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In Steffen et al. (2012), heterogeneity in pooled SBP (I2=72%) and DBP (I2=41%) analysis was explored by type of coffee, sex and prestudy BP in subgroup analyses, but no significant interactions were found.

    “Heterogeneity in the pooled SBP (I 2 = 72 %) and DBP (I 2 = 41 %) analysis was explored by considering type of coffee, sex and prestudy BP in subgroup analyses, but no significant interactions were found.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Steffen et al., 2012 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Previous meta-analyses have consistently reported positive associations between habitual consumption of caffeine-containing foods and beverages, mostly coffee, and the risk of cardiovascular disease from case-control studies, but not from prospective cohort studies.

    “Previous meta-analyses have consistently reported positive associations between habitual consumption of caffeine-containing foods and beverages (mostly coffee) and the risk of CVD from case-control studies, but not from prospective cohort studies (Greenland, 1993;Kawachi et al., 1994;Sofi et al., 2007).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Greenland, 1993 source

      Not checked in the free run.

    • cites Kawachi et al., 1994 source

      Not checked in the free run.

    • cites Sofi et al., 2007 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Caffeine from any source at doses ≥410 mg/day significantly increased SBP (mean 2.98, 95% CI 2.15-3.80) and DBP (mean 1.96, 95% CI 1.19-2.73), whereas caffeine doses <410 mg/day did not (SBP mean 0.72, 95% CI -0.35 to 1.78; DBP mean -0.52, 95% CI -1.62 to 0.57).

    “Caffeine from any source at doses ≥ 410 mg per day significantly increased SBP (mean 2.98, 95 % CI = 2.15-3.80)and DBP (mean 1.96, 95 % CI = 1.19-2.73),whereas caffeine doses < 410 mg per day did not (change in SBP = mean 0.72, 95 % CI = -0.35 to 1.78; change in DBP = mean -0.52, 95 % CI = -1.62 to 0.57).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Noordzij et al., 2005 source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Study design and conductnone given

    The tools used to assess self-reported anxiety have been developed to discriminate between children with high and low anxiety levels, rather than to assess changes in anxiety.

    “The Panel also notes that the above-mentioned tools to assess self-reported anxiety have been developed to discriminate between children with high and low anxiety levels, rather than to assess changes in anxiety.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Interpretationnone given

    The Panel considers that results obtained in children with attention deficit hyperactivity disorders cannot be extrapolated to children in the general population.

    “The Panel considers that results obtained in children with ADHD cannot be extrapolated to children in the general population and will not be further considered in this opinion”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In Noordzij et al. (2005), changes in SBP and DBP for coffee (18 strata) were 1.22 mmHg (0.52-1.92) and 0.49 mmHg (-0.06 to 1.04), and for caffeine (seven strata) were 4.16 mmHg (2.13-6.20) and 2.41 mmHg (0.98-3.84).

    “Changes (mean and 95 % CI) in SBP and DBP for coffee (18 strata) were 1.22 mmHg (0.52-1.92 mmHg) and 0.49 mmHg (-0.06 to 1.04 mmHg), and for caffeine (seven strata) were 4.16 mmHg (2.13-6.20 mmHg) and 2.41 mmHg (0.98-3.84 mmHg).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Noordzij et al., 2005 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    The Panel notes that caffeine intakes were not significantly associated with anxiety, and that caffeine concentrations in saliva were generally not associated with self-reported measures of anxiety in the Bernstein et al. study.

    “The Panel notes that caffeine intakes were not significantly associated with anxiety, and that caffeine concentrations in saliva were generally not associated with self-reported measures of anxiety in this study.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Bernstein et al., 1994 source

      Not checked in the free run.

  • May combine two claims.

    Study design and conductnone given

    The Panel notes that the studies available at doses of ≤3 mg/kg body weight have small sample sizes and are heterogeneous in design, and that doses between 3 and 10 mg/kg body weight per day have not been investigated.

    “The Panel also notes that the studies available at doses of ≤ 3 mg/kg bw have small sample sizes and are heterogeneous in design, and that doses between 3 and 10 mg/kg bw per day have not been investigated.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In Steffen et al. (2012), the pooled weighted difference in mean change of SBP was -0.55 mmHg (95% CI -2.46 to 1.36) and of DBP was -0.45 mmHg (95% CI -1.52 to 0.61).

    “The pooled weighted difference in mean change of SBP was -0.55 mmHg (95 % CI = -2.46 to 1.36 mmHg) and of DBP was -0.45 mmHg (95 % CI = -1.52 to 0.61 mmHg).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Steffen et al., 2012 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    In the context of this opinion, a reduction in the perceived exertion or effort during exercise can be considered a potential adverse health effect for the general population under the assumption that the perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical activities that may compromise the cardiovascular and/or musculoskeletal systems.

    “In the context of this opinion, however, a reduction in the perceived exertion/effort during exercise can be considered a potential adverse health effect for the general population (not limited to adults performing endurance exercise willing to obtain such an effect) under the assumption that the perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical activities that, because of their high intensity, extended duration or both, may compromise the cardiovascular and/or musculoskeletal systems.
  • Probably not a substantial claim: may not pass S4 (based).

    Study design and conductnone given

    Higher doses of alcohol have not been systematically investigated.

    “Higher doses of alcohol have not been systematically investigated.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Palatini et al. (2007) reported an increased risk of developing sustained hypertension associated with caffeinated coffee consumption compared with no consumption, with no significant difference in risk among categories of coffee intake.

    “the study by Palatini et al. (2007) reported an increased risk of developing sustained hypertension associated with caffeinated coffee consumption compared with no consumption, with no significant difference in risk among categories of coffee intake”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Palatini et al., 2007

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    The Panel notes that although the case-control study suggests polymorphisms of CYP1A2 may affect risk of MI in relation to caffeine consumption, which may be further affected by HTR2A polymorphisms, the results have not yet been replicated and the hypothesis has not been tested in prospective cohort studies.

    “The Panel notes that, although this case-control study suggests that polymorphisms of the CYP1A2 gene may affect the risk of MI in relation to caffeine consumption, which may be further affected by polymorphisms of the serotonin receptor gene HTR2A, the results have not yet been replicated and the hypothesis has not been tested in prospective cohort studies.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Cornelis et al., 2006 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Ding et al. (2014), compared with the lowest coffee consumption, RRs of CHD were 0.89 (95% CI 0.85-0.94) for the first category (median 1.5 cups/day), 0.90 (0.84-0.97) for the second (3.5 cups/day), and 0.93 (0.84-1.02) for the third (5 cups/day).

    “Compared with the lowest category of coffee consumption (median zero cups per day), the RRs of CHD were 0.89 (95 % CI = 0.85-0.94)for the first category (median 1.5 cups per day), 0.90 (95 % CI = 0.84-0.97)for the second category (median 3.5 cups per day) and 0.93 (95 % CI = 0.84-1.02)for the third category of coffee consumption (median five cups per day).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Ding et al., 2014 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Ding et al. (2014), coffee consumption was inversely associated with risk of CVD up to eight cups/day; no association was observed between coffee consumption and CHD risk at higher intake.

    “Coffee consumption was inversely associated with the risk of CVD up to eight cups per day.No association was observed between coffee consumption and CHD risk at higher intake.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Ding et al., 2014 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Sofi et al. (2007), cumulative RRs for CHD were 1.04 (95% CI 0.90-1.19) for one to two cups/day, 1.05 (0.90-1.22) for three to four cups/day, and 1.16 (0.95-1.41) for four or more cups/day compared with none or less than one cup/day.

    “The cumulative RR for all cohort studies was 1.04 (95 % CI = 0.90-1.19)for the first category of coffee consumption (one to two cups per day), 1.05 (95 % CI = 0.90-1.22)for the second category (three to four cups per day) and 1.16 (95 % CI = 0.95-1.41)for the third category (four or more cups per day) compared with the reference category (none or less than one cup per day).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Sofi et al., 2007 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In NHS I and II, significant inverse associations between intake of caffeinated coffee and risk of hypertension were observed in both cohorts, but not with decaffeinated coffee.

    “In multivariate models including beverage type, rather than actual caffeine intake, significant inverse associations between intake of caffeinated coffee (p for trend = 0.02 and 0.03 in NHS I and NHS II, respectively) and the risk of hypertension was observed in both cohorts, but an association was not found with decaffeinated coffee (p for trend = 0.08 and 0.67 in NHS I and NHS II, respectively).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Winkelmayer et al., 2005 source

      Not checked in the free run.

  • The quote only partly states this claim.

    Premisecitation

    Hodgson et al. (1999) found that changes in 24-hour ambulatory BP did not differ significantly among interventions (250 mg caffeine in hot water, black tea or green tea, five cups/day for seven days) with respect to baseline in 13 subjects with high-normal SBP and DBP.

    “Changes in 24-hour ambulatory BP did not differ significantly among interventions with respect to baseline.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Hodgson et al., 1999 source

      Not checked in the free run.

  • May combine two claims.

    Study design and conductown data

    The two Palatini studies exclusively enrolled subjects with never-treated stage 1 hypertension at baseline and do not provide information about the general (unselected) adult population.

    “However, these two studies exclusively enrolled subjects with never-treated stage 1 hypertension at baseline (incidence of hypertension requiring medication of 50.7 % in the six-year follow-up) and do not provide information about the general (unselected) adult population.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Palatini et al., 2007

      Not checked in the free run.

    • cites Palatini et al., 2009 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In a case-control study (Cornelis et al., 2006), among carriers of the slow *1F allele of CYP1A2, multivariate-adjusted ORs for non-fatal MI associated with consumption of less than one, one, two to three and four or more cups of coffee per day were 1.00, 0.99, 1.36, and 1.64, respectively; corresponding ORs for the rapid *1A/*1A genotype were 1.00, 0.75, 0.78, and 0.99 (p=0.04 for gene by coffee

    “In total, 55 % of cases (n = 1 114) and 54 % of controls (n = 1 082) were carriers of the slow *1F allele, for which the multivariate-adjusted odds ratios (ORs) and 95 % CIs for non-fatal MI associated with the consumption of less than one, one, two to three and four or more cups of coffee per day were 1.00 (reference), 0.99 (0.69-1.44), 1.36 (1.01-1.83)and 1.64 (1.14-2.34),respectively.Cor”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Cornelis et al., 2006 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Wu et al. (2009), pooled RRs of CHD for all studies combined were 0.96 (95% CI 0.87-1.06) for moderate, 1.04 (0.92-1.17) for heavy, and 1.07 (0.87-1.32) for very heavy coffee consumption.

    “The pooled RRs of CHD for all studies combined were 0.96 (95 % CI = 0.87-1.06)for the moderate, 1.04 (95 % CI = 0.92-1.17)for the heavy and 1.07 (95 % CI = 0.87-1.32)for the very heavy categories of coffee consumption.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Wu et al., 2009

      Not checked in the free run.

  • May combine two claims.

    Study design and conductcitation

    The Panel notes the low number of coffee abstainers and the low number of incident cases of hypertension in this group in Uiterwaal et al. (2007).

    “The Panel notes the low number of coffee abstainers included in the study and the low number of incident cases of hypertension in this group.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Uiterwaal et al., 2007 source

      Not checked in the free run.

  • May combine two claims. The quote only partly states this claim.

    Premisecitation

    In Grobbee et al. (1990), risk of CHD, CABG, PTCA, stroke or total CVD did not increase significantly across categories of caffeinated or decaffeinated coffee consumption or total caffeine intake, except for a significant p trend (0.04) for increased risk of CABG and PTCA in the highest category of decaffeinated coffee consumption.

    “The risk of CHD (total, non-fatal MI and fatal CHD), coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA), stroke or total CVD did not increase significantly across categories of caffeinated or decaffeinated coffee consumption (one or less cup, two to three cups and four or more cups per day compared with none) or of total caffeine intake (quintiles: 0-”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Grobbee et al., 1990 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Uiterwaal et al. (2007), higher coffee intake was not associated with an increased risk of hypertension, whereas coffee abstainers showed a decreased risk compared with the reference category.

    “In the study by Uiterwaal et al. (2007), where the category of more than zero to three cups per day was taken as the reference, higher coffee intake was not associated with an increased risk of hypertension, whereas coffee abstainers showed a decreased risk compared with the reference category.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Uiterwaal et al., 2007 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In NHS II, caffeinated tea intake was significantly associated with incident hypertension, but not in NHS I.

    “A significant association between caffeinated tea intake and incident hypertension was found in the cohort of younger women in NHS II (p for trend = 0.01), but not in NHS I (p for trend = 0.79).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Winkelmayer et al., 2005 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Greenberg et al. (2008), risk of CHD, stroke and total CVD did not increase significantly across categories of total caffeine intake or caffeinated beverages consumed; risk of CVD and CHD mortality significantly decreased across categories in subjects ≥65 years, normotensive individuals and subjects with untreated stage 1 hypertension, whereas decaffeinated beverages did not affect risk.

    “The risk of CHD, stroke and total CVD did not increase significantly across categories of total caffeine intake (> 30, 30-100, 100-350 and ≥ 350 mg per day) or of caffeinated beverages consumed (< 0.5, 0.5 to < 2, 2 to < 4 and ≥ 4 servings per day).The risk of CVD and CHD mortality significantly decreased across categories of caffeine and caffeinated beverages consumption in subjects ≥ 65 years of”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Greenberg et al., 2008 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    The Panel notes that almost no study reported an increased risk of CHD associated with habitual coffee consumption of four or less cups/day, corresponding to about 400 mg/day caffeine, which may be an underestimation of total caffeine intake.

    “The Panel also notes that almost no study reported an increased risk of CHD associated with habitual coffee consumption of four or less cups per day, corresponding to about 400 mg per day of caffeine, which may be an underestimation of total caffeine intake considering that other sources of caffeine were not taken into account in the majority of the studies”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In NHS I and II, categorical analysis found an inverse U-shaped association between caffeine consumption and incident hypertension; compared with the lowest quintile, the third quintile had significant 14% and 15% increased risk, whereas no increased risk was observed in the highest quintile.

    “Using categorical analysis, an inverse U-shaped association between caffeine consumption and incident hypertension was found.Compared with participants in the lowest quintile of caffeine consumption (mean intakes 14.8 and 19.6 mg per day), those in the third quintile (209.3 and 174.7 mg per day) had a significant 14 % and 15 % increased risk of hypertension in NHS I and NHS II, respectively,”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Winkelmayer et al., 2005 source

      Not checked in the free run.

  • May combine two claims. The quote only partly states this claim.

    Premisecitation

    In Hu et al. (2007), caffeinated coffee drinking was positively associated with initiation of antihypertensive treatment (p for trend=0.024), but the association was no longer significant when baseline BP was considered.

    “Caffeinated coffee drinking was also positively associated with initiation of antihypertensive treatment (p for trend = 0.024 across categories of coffee intake: zero to one cup per day, two to three cups per day, four to five cups per day, six to seven cups per day and eight or more cups per day) in the study by Hu et al. (2007), which enrolled never-treated hypertensive and normotensive subjects”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Hu et al., 2007

      Not checked in the free run.

  • May combine two claims.

    Study design and conductreasoning

    The Panel notes that the interaction between coffee intake and sex on the incidence of hypertension was not statistically significant, and thus subgroup analyses by sex were not statistically justified.

    “The Panel also notes that the interaction between coffee intake and sex on the incidence of hypertension was not statistically significant, and thus subgroup analyses by sex were not statistically justified.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationnone given

    Although polymorphisms of the CYP1A2 gene may affect the risk of hypertension associated with caffeine consumption, this hypothesis has not been tested prospectively in unselected populations.

    “Although it has been suggested that polymorphisms of the CYP1A2 gene may affect the risk of hypertension associated with caffeine consumption and explain in part the different findings among studies, this hypothesis has not been tested prospectively in unselected populations.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    In a dose-response meta-analysis, the best-fitting model showed an inverse J-shaped curve (p for quadratic <0.001), with risk of hypertension increasing up to three cups/day (RR 1.07, 95% CI 0.97-1.20) and decreasing with higher intake (RR for six cups vs zero: 0.99, 95% CI 0.89-1.10).

    “In a dose-response meta-analysis, the best-fitting model showed an inverse “J-shaped” curve (p for quadratic term < 0.001), with the risk of hypertension increasing up to three cups per day (RR for the comparison of three cups with zero cups per day: 1.07, 95 % CI = 0.97-1.20)and decreasing with higher intake (RR for the comparison of six cups with zero cups per day: 0.99, 95 % CI = 0.89-1.10).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Zhang et al., 2011 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In Jee et al. (1999), a significant effect of caffeinated coffee on BP was observed only by pooling studies using five or more cups of coffee, but not in studies using ≤4.5 cups.

    “A significant effect of caffeinated coffee on BP was observed only by pooling studies using five or more cups of coffee, but not in studies using ≤ 4.5 cups.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Jee et al., 1999 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    The Panel notes that different types of caffeinated beverages were differently associated with risk of incident hypertension: caffeinated coffee inversely, caffeinated tea (in one cohort) and cola beverages directly.

    “The Panel also notes that different types of caffeinated beverages were differently associated with the risk of incident hypertension.Whereas caffeinated (but not decaffeinated) coffee was inversely associated with the risk of hypertension, caffeinated tea (in one cohort) and cola beverages (in both cohorts) were directly associated with that risk.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Winkelmayer et al., 2005 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In the CARE Study Group, caffeine consumption of > 200 mg per day during pregnancy was associated with a reduction in birth weight of about 60-70 g, with a significant trend for greater reduction in birth weight with higher caffeine intake (p = 0.004).

    “Caffeine consumption of > 200 mg per day during pregnancy was associated with a reduction in birth weight of about 60-70 g, with a significant trend for greater reduction in birth weight with higher caffeine intake (p = 0.004).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites CARE Study Group, 2008 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Prospective cohort studies on the relationship between habitual caffeine intake and long-term changes in BP and on the risk of incident hypertension are conflicting and difficult to interpret.

    “Prospective cohort studies on the relationship between habitual caffeine intake and long-term changes in BP and on the risk of incident hypertension are conflicting and difficult to interpret.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Overall, the results from case-control and cross-sectional studies support a positive association between caffeine intake and the risk of adverse birth weight-related outcomes, whereas the relationship between caffeine consumption during pregnancy and other pregnancy outcomes was less consistent.

    “Overall, the results from these studies support a positive association between caffeine intake and the risk of adverse birth weight-related outcomes, whereas the relationship between caffeine consumption during pregnancy and other pregnancy outcomes (e.g. in relation to length of gestation or fetal death) was less consistent (COT, 2008)”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites COT, 2008

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    The Panel notes that the CARE Study Group shows a dose-dependent positive association between caffeine intake during pregnancy and adverse birth weight- and fetal death-related outcomes, and that the risk becomes significant at caffeine doses ≥ 200 mg per day for FGR and at ≥ 300 mg per day for late miscarriage or stillbirth.

    “The Panel notes that this study shows a dose-dependent positive association between caffeine intake during pregnancy and adverse birth weight-and fetal death-related outcomes, and that the risk becomes significant at caffeine doses ≥ 200 mg per day for FGR and at ≥ 300 mg per day for late miscarriage or stillbirth.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In the Sengpiel et al. (2013) study, total and coffee caffeine intakes were significantly associated with higher odds for SGA in all three SGA models, and with soft drink and black tea caffeine in two SGA models.

    “Total and coffee caffeine intakes were significantly associated with higher odds for SGA in all three SGA models, and with soft drink and black tea caffeine in two SGA models.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Sengpiel et al., 2013 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Similar results were obtained in the meta-analysis by Kim et al. (2012).

    “Similar results were obtained in the meta-analysis by Kim et al. (2012)”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Kim et al. (2012) source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In the Sengpiel et al. (2013) study, total caffeine and soft drink caffeine were significantly associated with decreased gestational length in non-coffee drinkers, whereas no association was found with black tea or chocolate caffeine.

    “Conversely, total caffeine and soft drink caffeine were significantly associated with decreased gestational length in non-coffee drinkers, whereas no association was found with black tea or chocolate caffeine.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Sengpiel et al., 2013 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In the McMahon et al. (2014) study, both genotypes were individually associated with total caffeine consumption and with the consumption of caffeinated drinks at all time points, but not with the consumption of decaffeinated drinks.

    “Both genotypes were individually associated with total caffeine consumption and with the consumption of caffeinated drinks (coffee and tea) at all time points, but not with the consumption of decaffeinated drinks.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites McMahon et al., 2014 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In the McMahon et al. (2014) study, the proportion of phenotypic variance explained by the two genotypes was small: CYP1A1 accounted for 0.15-0.88%, AHR for 0.04-0.048%, and the two combined for about 0.16-1.28%.

    “the proportion of phenotypic variance (i.e.observed variability in caffeine intake) explained by these two genotypes was small: CYP1A1 accounted for 0.15-0.88%, AHR accounted for 0.04-0.048% and the two combined accounted for about 0.16-1.28%.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites McMahon et al., 2014 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    The Panel notes that the Sengpiel et al. (2013) study shows a dose-dependent positive association between caffeine intake during pregnancy and adverse birth weight-related outcomes, with risk becoming statistically significant at caffeine doses > 50 mg per day but increasing notably at > 200 mg per day.

    “The Panel notes that this study shows a dose-dependent positive association between caffeine intake during pregnancy and adverse birth weight-related outcomes.The risk becomes statistically significant at caffeine doses > 50 mg per day but increases notably at > 200 mg per day.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In the study by Lopez-Garcia et al. (2009), total caffeine intake, consumption of caffeinated beverages and consumption of decaffeinated coffee were not significantly associated with an increased risk of stroke.

    “Total caffeine intake, consumption of caffeinated beverages (tea, caffeinated soft drink and caffeinated coffee) and consumption of decaffeinated coffee were not significantly associated with an increased risk of stroke.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Lopez-Garcia et al. (2009)

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    The conclusion that single doses of caffeine up to 200 mg are unlikely to induce clinically relevant changes in MBF may not hold when caffeine is consumed prior to physical exercise under unusual environmental conditions such as very high altitude.

    “The Panel notes that this may not be the case when caffeine is consumed prior to physical exercise under unusual environmental conditions (e.g.very high altitude).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Single doses of caffeine of no concern derived for adults (3 mg/kg bw per day) may also apply to children, considering that caffeine clearance in children and adolescents is at least that of adults, and that the limited studies available on the acute effects of caffeine on anxiety and behaviour in children and adolescents support this level of no concern.

    “The Panel considers that single doses of caffeine of no concern derived for adults (3 mg/kg bw per day) may also apply to children, considering that caffeine clearance in children and adolescents is at least that of adults, and that the limited studies available on the acute effects of caffeine on anxiety and behaviour in children and adolescents support this level of no concern.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Caffeine clearance in children and adolescents is at least that of adults.
  • May combine two claims.

    Study design and conductcitation

    95th percentile caffeine intake estimates based on dietary surveys or age classes with fewer than 60 days of data may not be statistically robust, and were consequently not considered.

    “(a): The 95 th percentile estimates based on dietary surveys/age classes with fewer than 60 days of data may not be statistically robust (EFSA, 2011b) and consequently were not considered (-).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites EFSA, 2011b

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    The approach of setting a level of no safety concern for habitual caffeine consumption by children and adolescents at 3 mg/kg bw per day is rather conservative in relation to the effects of caffeine on the cardiovascular system, but the limited studies available regarding the longer-term effects of caffeine on anxiety and behaviour support this caffeine intake level of no safety concern.

    “The Panel notes that this approach is rather conservative in relation to the effects of caffeine on the CVS, but the limited studies available regarding the longer-term effects of caffeine on anxiety and behaviour in children and adolescents support this caffeine intake level of no safety concern.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The same levels of no concern derived for adults (5.7 mg/kg bw for a 70-kg adult) may also apply to children, unless there are data showing a higher sensitivity to the effects of caffeine in this age group.

    “Therefore, the same levels of no concern derived for adults (i.e.5.7 mg/kg bw for a 70-kg adult) may also apply to children, unless there are data showing a higher sensitivity to the effects of caffeine of this age group (i.e.difference in pharmacodynamics).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Caffeine clearance in children and adolescents is at least that of adults.
  • May combine two claims.

    Premisenone given

    No health concerns in relation to acute toxicity, bone status, cardiovascular health, cancer risk or male fertility have been raised by other bodies in previous assessments for habitual caffeine consumption up to 400 mg per day, and no new data have become available on these or other clinical outcomes which could justify modifying these conclusions.

    “No health concerns in relation to acute toxicity, bone status, cardiovascular health, cancer risk or male fertility have been raised by other bodies in previous assessments for this level of habitual caffeine consumption and no new data have become available on these or other clinical outcomes which could justify modifying these conclusions.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Daily caffeine intakes by the breastfed infant would not exceed 0.3 mg/kg bw, which is 10-fold below the lowest dose of 3 mg/kg bw tested in a dose finding study.

    “Daily caffeine intakes by the breastfed infant would not exceed 0.3 mg/kg bw (Hildebrandt and Gundert-Remy, 1983), which is 10-fold below the lowest dose of 3 mg/kg bw tested in a dose finding study (Steer et al., 2003).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Hildebrandt and Gundert-Remy, 1983

      Not checked in the free run.

    • cites Steer et al., 2003 source

      Not checked in the free run.

  • The quote only partly states this claim.

    Interpretationreasoning

    The use of a conservative caffeine value for chocolate beverages may have led to an overestimation of caffeine intakes in children and toddlers.

    “The Panel notes that chocolate beverages were important contributors to total caffeine intakes in this age group in most countries, and that the use of a conservative caffeine value for this food category may have led to an overestimation of caffeine intakes in children.”
    Quote in the paperNot a substantial claim
194 of 194
  • The paper relies on this without support.

    Caffeine clearance in children and adolescents is at least that of adults.

    “considering that caffeine clearance in children and adolescents is at least that of adults”
    “As caffeine clearance in children and adolescents is at least that of adults”
    “considering that caffeine clearance in children and adolescents is at least that of adults”
    “As mentioned above, caffeine clearance in children and adolescents is at least that of adults.”
  • The paper relies on this without support.

    Caffeine is not an essential nutrient.

    “However, caffeine is not an essential nutrient, and thus ULs cannot be derived.”
  • The paper relies on this without support.

    No data show a higher sensitivity to the effects of caffeine in children and adolescents (i.e., difference in pharmacodynamics).

    “unless there are data showing a higher sensitivity to the effects of caffeine in this age group (i.e.difference in pharmacodynamics).”
  • The paper relies on this without support.

    Cocoa-based beverages might present significant variability in caffeine levels because of the amount and type of cocoa present in different brands.

    “Cocoa-based beverages are another food product that might present significant variability in caffeine levels because of the amount and type of cocoa present in the different brands.”
  • The paper relies on this without support.

    Food frequency questionnaires specifically developed to assess consumption of specific foods tend to overestimate consumption of such foods.

    “(ii) FFQs specifically developed to assess consumption of specific foods tend to overestimate consumption of such foods;”
  • The paper relies on this without support.

    The dietary surveys included in the EFSA Comprehensive Database provide representative estimates of caffeine intake for the respective populations.

    “Daily caffeine intake from all sources could be estimated for adults from 16 Member States.”
  • The paper relies on this without support.

    The EFSA energy drink report data are representative of energy drink consumers in the EU.

    “Data were available from 16 Member States (Zucconi et al., 2013).”
  • The paper relies on this without support.

    Caffeine is a non-selective competitive A2A receptor antagonist that counteracts the vasodilator effect of adenosine and other A2A receptor agonists in the coronary arteries, where the density of such receptors is particularly high.

    “Caffeine (like other methylxanthines) is a non-selective competitive A 2A receptor antagonist which counteracts the vasodilator effect of adenosine and other A 2A receptor agonists in the coronary arteries, where the density of such receptors is particularly high.”
  • The paper relies on this without support.

    The cardiac hyperaemic response to physical exercise is primarily mediated by endogenous production of adenosine by myocytes as a consequence of hypoxia, which induces vasodilation of the coronary arteries.

    “The cardiac hyperaemic response to physical exercise is primarily mediated by the endogenous production of adenosine by myocytes as a consequence of hypoxia, which induces vasodilation of the coronary arteries.”
  • The paper relies on this without support.

    p-Synephrine has direct stimulant effects on the sympathetic nervous system, primarily via the α1- and β-adrenoreceptors.

    “p-Synephrine has direct stimulant effects on the sympathetic nervous system, primarily via the α 1 -and β-adrenoreceptors.”
  • The paper relies on this without support.

    Synephrine is more hydrophilic than ephedrine and amphetamines, leading to lower transit across the blood-brain barrier and consequently lower or no central nervous system stimulation.

    “In contrast with ephedrine and amphetamines, which have known psychostimulating effects in the CNS, synephrine is more hydrophilic, which leads to a lower transit across the blood-brain barrier and consequently to lower, or no, CNS stimulation.”
  • The authors state this as an assumption.

    The perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical activities that, because of their high intensity, extended duration or both, may compromise the cardiovascular and/or musculoskeletal systems.

    “under the assumption that the perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical activities that, because of their high intensity, extended duration or both, may compromise the cardiovascular and/or musculoskeletal systems.”
  • The paper relies on this without support.

    FGR and SGA are associated with increased risk of perinatal morbidity and mortality.

    “FGR and SGA are associated with increased risk of perinatal morbidity and mortality.”
  • The paper relies on this without support.

    FGR is correlated with increased risk of metabolic diseases later in life.

    “FGR has been found to be correlated with increased risk of metabolic diseases later in life.”
  • The paper relies on this without support.

    Hypertension is an established risk factor for CVD, and in particular for stroke, CHD and heart failure.

    “Hypertension is an established risk factor for CVD, and in particular for stroke, CHD and heart failure.”
  • The authors state this as an assumption.

    The relationship between caffeine intake during pregnancy and adverse birth weight-related outcomes is causal in the context of this safety assessment.

    “the Panel assumes that the relationship is causal in the context of this safety assessment.”
  • The paper relies on this without support.

    The half-life of caffeine in women is mean four hours, range two to eight hours, and the half-life in infants is longer, namely 50-103 hours in neonates with no CYP1A2 activity and about 14 hours at three to four months of age.

    “the half-life of caffeine (mean four hours, range two to eight hours) in women and the longer half-life in infants (i.e.50-103 hours in neonates with no CYP1A2 activity, about 14 hours at three to four months of age).”
17 of 17

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Caffeine stimulates sympathetic nervous system activity and easily crosses the blood-brain barrier with stimulatory effects on the CNS.

    “It is consumed from the diet and absorbed into the blood, stimulates the sympathetic nervous system activity, and easily crosses the blood–brain barrier (BBB) with stimulatory effects also on the central nervous system (CNS) [196,200].”

    From Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis (2020) · cites this paper as [200]

    Section 4.1.1 says caffeine is rapidly absorbed after oral intake and freely crosses the blood–brain barrier; section 4.2 describes its psychomotor stimulant effect in the CNS. Section 4.4.1 lists sympathetic nervous system activation as a possible mechanism of caffeine’s acute cardiovascular effects, but says the contribution of that mechanism is unclear. The citing sentence presents sympathetic stimulation without that qualification. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • The European Food Safety Authority concluded that a single dose of 200 mg or less of caffeine, as well as chronic intakes at or below 200 mg, consumed by lactating women pose no safety concerns for breastfed infants.

    “the European Food Safety Authority concluded that a single dose of 200 mg or less of caffeine (about two cups) consumed by lactating women, as well as chronic intakes at or below 200 mg, pose no safety concerns for breastfed infants (151).”

    From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [151]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • CARE study's energy-drink contribution is reported as both 1% and about 2%

    Minor

    The CARE study's source breakdown assigns energy drinks 1% of caffeine intake, while the later summary describes their contribution alone as about 2%.

1 of 1

Cites

Flagged first, then by citations

13 of the 309 references couldn’t be matched to a known paper.

Research works printed but not linked: 6

  1. EFSA (European Food Safety Authority), 2009, Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (ANS) on a request from the European Commission on the use of taurine and D‐glucurono‐γ‐lactone as constituents of the so‐called “energy” drinks, The EFSA Journal, 935, 1
  2. Evira, 2013, Food supplements containing synephrine and caffeine withdrawn from sale, 15, 22
  3. Jacobsen, 1986, Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study, Journal of the National Cancer Institute, 76, 823
  4. Kalman, 2002, A double blind clinical evaluation of the metabolic effects of Xenadrine EFXTM compared to two ephedra‐containing products in normal healthy volunteers. Presented at the annual meeting of the American College of Nutrition, Abstract No. 101, Journal of the American College of Nutrition, 21, 488
  5. SHC (Superior Health Council), 2012, “The use of caffeine in foodstuffs”, 27
  6. Zhang, 2009, Coffee consumption and risk of cardiovascular disease and total mortality among women with type 2 diabetes, Circulation, 119, E298

Cited by

Sorted by citations

Authors
EFSA Panel on Dietetic Products, N. A. A. (.
Corresponding author
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Venue
EFSA Journal
Publisher
Wiley
Published
2015-05
Volume
13
Issue
5
ISSN
1831-4732 (ISSN-L)
OpenAlex
W2556574846
Cited by
613
References
309
Citations by year
2026: 65 · 2025: 73 · 2024: 72 · 2023: 56 · 2022: 62 · 2021: 90 · 2020: 45 · 2019: 38 · 2018: 48 · 2017: 38 · 2016: 19 · 2015: 6
FWCI
26.70
Type
journal article
Language
en
Open access
Locations
  • EFSA Journal (publishedVersion, cc-by-nd)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Pharmacology › Coffee research and impacts
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Agricultural safety and regulations
  • Physical Sciences › Chemistry › Analytical Chemistry › Dye analysis and toxicity
Keywords
caffeine, food safety, dietary intake, energy drinks, p-synephrine, alcohol, physical activity, taurine, pregnancy, lactation, breastfeeding, children and adolescents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review